Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christina F. Budden
Observed names:
Christina Budden,
Christina F. Budden
Institution:
Novartis (Germany)
Observed institutions:
Leiden University,
University of Bonn,
The University of Melbourne,
University Hospital Bonn,
Leiden University Medical Center,
Hudson Institute of Medical Research,
Novartis (Germany),
Peter Doherty Institute
show all 8
ORCID:
0000-0003-0862-0119
Observed ORCID:
0000-0003-0862-0119
OpenAlex ID:
A5087151206
Butyrate and propionate are microbial danger signals that activate the NLRP3 inflammasome in human macrophages upon TLR stimulation
2024
·
Wei Wang
, Alesja Dernst
, et al.
·
Cell Reports
·
109
Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2014
·
Gijs G. Zom
, Selina Khan
, et al.
·
Cancer Immunology Research
·
97
PDF
Inflammasome‐induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses
2021
·
Christina F. Budden
, Linden J. Gearing
, et al.
·
Journal of Extracellular Vesicles
·
63
PDF
CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs
2024
·
Andreas Schneeweiss
, Sara Y. Brucker
, et al.
·
Geburtshilfe und Frauenheilkunde
·
8
IRGB10 Exposes Bacteria’s Intimate Secrets
2016
·
Florian Hoss
, Christina F. Budden
, et al.
·
Developmental Cell
·
3
PDF
Butyrate and propionate are microbial danger signals that activate the NLRP3-inflammasome in human macrophages in the presence of TLR stimulation
2024
·
Wei Wang
, Alesya Dernst
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
CDK4/6-Inhibition: Sequenztherapien und die Suche nach den besten Biomarkern – ein Überblick über die aktuellen Programme
2025
·
Andreas Schneeweiss
, Sara Y. Brucker
, et al.
·
Senologie - Zeitschrift für Mammadiagnostik und -therapie
Supplementary Figure 1 from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2023
·
Gijs G. Zom
, Selina Khan
, et al.
Supplementary Figure 2 from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2023
·
Gijs G. Zom
, Selina Khan
, et al.
Supplementary Figure Legends from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2023
·
Gijs G. Zom
, Selina Khan
, et al.
Data from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2023
·
Gijs G. Zom
, Selina Khan
, et al.
Supplementary Figure Legends from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2023
·
Gijs G. Zom
, Selina Khan
, et al.
Supplementary Figure 2 from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2023
·
Gijs G. Zom
, Selina Khan
, et al.
PDF
Supplementary Figure 1 from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2023
·
Gijs G. Zom
, Selina Khan
, et al.
PDF
Data from Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates
2023
·
Gijs G. Zom
, Selina Khan
, et al.
Characterisation of extracellular vesicles released upon NLRP3 activation and their impact on bystander cells
2019
·
Christina F. Budden
·
bonndoc (University of Bonn)
Show more works
View as search
Works count:
16
Citation count:
282
H-index:
4
I10-index:
3
Year
Topic
Type
